Study to Compare the Effects of Moderate Liver Impairment on the Pharmacokinetics (PK) of PF-07321332 Enhanced With Ritonavir in Participants With Moderate Abnormal Liver Function Compared to Healthy Participants With Normal Liver Function. [A Phase 1, Non-Randomized, Open-Label Study to Assess the Pharmacokinetics, Safety and Tolerability of PF-07321332 Boosted With Ritonavir in Adult Participants With Moderate Hepatic Impairment and Healthy
Participants With Normal Hepatic Function.